Dr Seshadri Vasan is Senior Business Development Manager for Public Health England (PHE) and prior to that for the Health Protection Agency. A former McKinsey Consultant and Rhodes Scholar, he previously worked as the Head of Public Health for Oxford University’s spin-out company Oxitec Limited, which was recently acquired for $160m. He is PHE’s business lead for Ebola-related activities, global health, innovation and international consultancy, and a member of Finance and Commercial Wider Senior Leadership Team, Global Health Strategy Delivery Group, Opportunities Assessment Group and Intellectual Property Sub-Group. Dr Vasan also represents PHE’s overseas commercial engagement in the UK Interlab Forum and is a member of the Task 4 Filo Group of the Australia-Canada-UK-US Medical Counter-Measures Consortium. He obtained his doctorate from Trinity College, Oxford, and is a Fellow of the Royal Society of Medicine, Royal Entomological Society and Royal Society for Public Health.